| BAP | Bioactive Peptide |
| AMP | Antimicrobial Peptide |
| APD3 | Antimicrobial Peptide Database 3 |
| AMR | Antibiotic Resistance |
| WHO | World Health Organization |
| MERS | Middle East respiratory syndrome |
| SARS | Severe acute respiratory syndrome |
| AVP | Antiviral peptides |
| AFP | Antifungal peptides |
| SPPS | Solid-phase Peptide Synthesis |
| HBTU | O-benzotriazole-N,N,N′,N′-tetramethyl-uronium-hexafluoro-phosphate |
| HATU | O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate |
| DIC | N,N′-diisopropylcarbodiimide |
| CCK | Cyclic Cystine Knot |
| DMF | Dimethylformamide |
| UAE | Ultrasound-assisted extraction |
| PEF | Pulsed electric fields |
| HHP | High hydrostatic pressure |
| AI | Artificial Intelligence |
| ML | Machine Learning |
| GST | Glutathione S-transferase |
| MBP | Maltose-binding protein |
| GRAS | Generally recognized as safe |
| PG | Phosphatidylglycerol |
| CL | Cardiolipin |
| PS | Phosphatidylserine |
| LPS | Lipopolysaccharides |
| HSPG | Heparan sulfate proteoglycan |
| HCMV | Human cytomegaloviruses |
| MCMV | Murine cytomegaloviruses |
| DHFR | Dihydrofolate reductase |
| TCA | Tricarboxylic acid |
| SQR | Succinate-coenzyme Q reductase |
| ROS | Reactive oxygen species |
| HSV-1 | Simplex virus type 1 |
| HDPs | Host defense peptides |
| LBP | Binding protein |
| FDA | Food and Drug Administration |
| IV | Intravenous injections |
| IM | Intramuscular injections |
| SC | Subcutaneous injections |
| CS/SA | Chitosan/sodium alginate |
| QSAR | Quantitative Structure–Activity Relationship |
| CNNs | Convolutional Neural Networks |
| DNNs | Deep Neural Networks |
| RNNs | Recurrent Neural Networks |
| VAEs | Variational Autoencoders |
| GANs | Generative Adversarial Networks |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| DL | Deep learning |
| SVM | Support vector machines |
| AIR | Ambiguous interaction restraints (AIRs). |